Terry Bruggeman | Benefunder
Terry Bruggeman
Advisory Board Member
Terry Bruggeman

Terry Bruggeman currently serves as executive chairman of BioTork, LLC and Evolugate LLC. Mr. Bruggeman’s career has included: general partner of a private equity firm; COO and CEO of private equity and venture–backed companies, co-founder of a leasing company; treasurer and CFO of two NYSE listed public companies; and an investment banker focused on restructuring underperforming and troubled companies.

In 1996, he became chairman, president and CEO of Diversa Corporation, (NASD: DVSA), now BASF/Verenium Corporation, a biotechnology company that became the global leader in the discovery of novel bioactive compounds for use in industrial applications, chemical processing, agriculture and pharmaceuticals.

Mr. Bruggeman received his BA from the University of Notre Dame and attended the MBA program at the University of Chicago Booth School of Business.